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S104 Am JIntroductionTheaging of the Baby Boomer population, the roughly69 million adults who were born in the U.S. between1946 and 1964, presents a number of important
public health challenges. This cohort that now represents
26.4% of the total U.S. population is living longer than any
cohort that came before it. Men aged 65 years are projected
to live to age 83 years, and women aged 65 years are
projected to live to 85 years, compared to about 46 years for
men and 48 years for women in 1900.1,2 This trend toward
increased longevity is expected to continue, with the number
of adults agedZ65 years increasing from 35 million, or 13%
of the U.S. population, in 2010 to 72 million, or 20% of the
population, in 2030.3 As many have pointed out, we are only
now realizing the potential impact of this increase in
longevity and remain ill-prepared to address it.4
The growing number of the aging population in the U.S.
has major implications for cancer prevention and control.
That the cumulative risk of developing cancer continues to
expand until about age 70 years suggests that the number
of middle- and older-aged people who are at risk for
developing some type of cancer during their lifetimes will
continue to increase as the population grows.2 Addressing
modiﬁable risk factors for cancer in childhood through
middle adulthood thus seems essential to improving the
lives of this growing segment of the population. In fact, it
has implications for the health of the nation as a whole.5
Realizing the need to set an agenda for cancer prevention
inmidlife, the Division of Cancer Prevention and Control at
the CDC brought together in 2012 an expert panel of
investigators from a range of disciplines and approaches to
acquiring knowledge. The purpose was to discuss cancer
risk in middle adulthood, with a shared aim of preventing
cancer.6 This workshop was part of an innovative CDC-
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Open access uLifespan. The workshop on cancer prevention during
midlife followed a 2011 CDC-sponsored workshop on
preadolescent and adolescent exposures and risk for adult
cancer.7 Taken together, the two workshops represent an
innovative approach to cancer prevention, one that takes
into account the intersections of age, cancer risk, and cancer
prevention, with consideration for how they might vary by
race/ethnicity, SES, and considerable comorbidities such as
serious mental illness.
Although taking such an integrated and holistic
approach is admirable, it presents major challenges to
advancing the expert panel’s agenda for cancer prevention
during key periods of the life cycle. Not only would it
require convening diverse groups of experts such as those
who participated in the 2011 and 2012 CDC-sponsored
workshops and expanding them to include scholars with
newly identiﬁed areas of pertinent expertise, such as experts
at the intersection of developmental biology and race, but
its success also would depend on the ability to develop an
infrastructure for fostering these kinds of collaborations. In
order to inform such an approach, the argument is posited
in this article for a means of capturing the complexity of
age, cancer risk, and cancer prevention in the context of
race/ethnicity, SES, and comorbidities, using ﬁndings from
the 2012 CDC-sponsored expert panel on cancer preven-
tion during midlife. In doing so, speciﬁc suggestions are
offered for developing and sustaining such an approach.Exploring a Case for a Developmental
Approach to Primary Cancer Prevention
White and colleagues2 make a strong argument for the
wisdom of taking a developmental approach to prevent-
ing cancer in midlife and older adulthood, noting that
cancers develop over a period of many years and that
many of the more than half of cancers diagnosed in 2009
were in adults aged Z65 years. Colditz and colleagues5
cite evidence of a 13- to 28-year span from initial cellular
changes to diagnosed metastatic disease in pancreatic
cancers8 to support their contention that beneﬁts are best
achieved through prevention that is timed earlier in life.
Although chronologic aging cannot be linked directly
to the development of diseases such as cancer (i.e., one’srican Journal of Preventive Medicine  Published by Elsevier Inc.
nder CC BY-NC-ND license.
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additional year of life), aging involves a series of
biological processes that may predispose a person to
cancer and other diseases. One example is cumulative
exposure to environmental pathogens such as pesticides
that are known to contribute to the development of
cancer and other diseases. Ory et al.9 write about midlife
as a watershed in which host immunity begins to decline
and the effects of risks and exposures accumulate. Like-
wise, poor health habits like smoking, sun exposure, and
inactivity, which have been linked to a number of chronic
diseases including cancer, begin to take their toll during
midlife and continue to accumulate into older adulthood.
Recent evidence10 that DNA methylation age of tissue
measures the cumulative effect of an epigenetic main-
tenance system provides promise for helping to under-
stand the relationships among age, developmental
biology, and cancer.
White and colleagues2 make a strong case for midlife
as a critical period of focus for primary cancer preven-
tion, while at the same time acknowledging that a
deﬁnition of midlife as ages 45–64 years may be some-
what arbitrary. Just as preadolescence and adolescence
are times when positive health habits can be shaped and
individuals and their families can begin to set a course for
minimizing harmful exposures like radiation, midlife also
represents a period when positive change is possible.
Although harmful health behaviors may persist through
young adulthood into middle adulthood, Ory et al.9 note
that the relative stability of middle adulthood allows
more opportunities for health behavior change than do
earlier phases of the life cycle.
For many adults in the U.S., midlife is a time when
family life and work begin to stabilize. Workers achieve
seniority, and their employment may provide health-
enhancing beneﬁts like insurance coverage and a plat-
form for worksite wellness programs. Midlife also often
brings a lightening of responsibilities within the nuclear
family. Rolland11 characterizes midlife as a centrifugal
period in the family life cycle, in the sense that parents
can focus outward, beyond the immediate activities of
childrearing. Child care duties decrease as children leave
home to begin their own lives, allowing parents to focus
on their own lives. At the same time, individuals are
exposed to the aging of their friends, colleagues, and
parents, which may sensitize them to their own health.
Thus, midlife can be seen as a period when adults are able
to focus their behavior change efforts to reduce their risk
for developing cancer, fostered by access to venues and
supports for substituting healthful for less healthful
behaviors.
The wisdom of targeting midlife for prevention of
cancer during older adulthood depends on evidence thatMarch 2014changes in behavior during midlife can in fact modify
risk for cancer later in life. Evidence from studies of
immigrants who change from one lifestyle to another or
populations experiencing industrialization reveal large
changes in cancer risk, although such studies do not
reveal when in life these behaviors or exposures
occurred.5 Colditz et al.5 calculate relatively rapid drops
in cancer incidence (i.e., from 2 to 20 years) after a
number of behavior changes and interventions (e.g.,
folate intake and risk for colorectal cancer) as evidence
that cancer can indeed be prevented. Studies such as that
of Coombs and colleagues12 ﬁnd that when hormone
replacement therapy use fell from 25% to 11.3% between
2000 and 2005, breast cancer incidence among women
aged 40–79 years decreased by 8.8% suggests that breast
cancer incidence can indeed be modiﬁed through health
behavior change during midlife.2
The Determinants of Cancer Risk During
Midlife and Other Phases of Development
Although the work of the 2011 and 2012 CDC expert
panels contributes markedly to our understanding of
cancer risk and cancer prevention across the life cycle,
little is known about how age, cancer risk, and cancer
prevention operate among members of racial and ethnic
minority groups and lower-SES populations to affect
cancer risk. Yet, acquiring this information is essential to
successively advancing the expert panel’s agenda for
cancer prevention.
Efforts have been made in recent years to understand
the determinants of cancer by recognizing that they occur
at multiple interacting levels of inﬂuence, and that
reducing cancer requires devising interventions that target
more than one of those levels. Expert panel members’
investigations span levels of analysis. They range from the
investigation of individual risk factors such as alcohol
consumption13 to the investigation of worksite practices
and sleep in fatal ovarian14 and prostate cancer15 to an
analysis of how changes in federal policy on folic acid
fortiﬁcation has affected rates of colorectal cancer.16
Importantly, panel members expanded from the prevail-
ing focus on individual risk factors such tobacco, diet,
physical activity, and obesity to include highly prevalent
factors such as social and physical context and policies.
A ﬁrst step in integrating the work of the expert panel
is organizing these investigations into a multilevel model.
Previous multilevel models portray factors from the
microbiologic to the societal and make clear that they
interact with one another in complex ways. One example
is a 2008 framework developed by Hiatt and Breen17 that
includes four levels: biological, behavioral/psychological,
healthcare systems, and social determinants. Warnecke
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(biological/genetic pathways, individual risk factors,
social relationships, social/physical context, institutions,
and social conditions and policies). In this model race,
age, and SES are included at the individual risk factors
level, along with health behaviors such as tobacco use and
diet, in order to capture their effects on behavior.18 In
addition, factors that might differentially expose racial/
ethnic groups to cancer and thus help to explain
increased mortality among racial/ethnic minority groups,
such as segregation, discrimination, and racism, are
included at other levels of the model. Segregation, for
example, is included at the social/physical context level.
Situating Cancer Risk Along the
Developmental Continuum
Although the multilevel models described above help to
contextualize cancer risk and include chronologic age as
an individual risk factor, none to date has considered
how interactions among multiple levels of inﬂuence
might vary across the developmental continuum.
Figure 1 portrays multilevel determinants of cancer risk
as proposed by Warnecke and colleagues18 across the ﬁve
developmental stages outlined by Ory et al.9 Considering
developmental phase in a multilevel model of cancer risk
seems prudent for at least two major reasons. First,
meaningful factors may vary by race/ethnicity. A number
of factors at the biological/genetic pathways level, for
example, are known to vary by race/ethnicity. The onset
of puberty, a risk factor for breast cancer, is signiﬁcantly
earlier for African-American than for white girls.19 An
examination of data in the Third National Health andFigure 1. Multilevel model of the determinants of cancer and ca
developmental continuumNutrition Examination Survey by Chumlea and collea-
gues20 also found the age at menarche, one marker of the
puberty transition, to occur considerably earlier in
African-American than white and Mexican-American
girls. Others have posited that social factors to some
extent shape biological pathways to produce these
differences.21
The second way in which multilevel models might vary
by race is that certain levels of analysis are likely to be
more salient during certain phases of development than
others, which might alter the way in which factors at
these levels interact with factors at other levels. The
theory of developmental plasticity, for example, tells us
that puberty is a period of high sensitivity to chemical
exposures and other environmental stressors.22 Hilakivi-
Clarke et al.23 found that high estrogenic fetal environ-
ments silence BRCA1 in daughters through methylation,
resulting in less BRCA1 to defend cells from becoming
cancerous. Also, decreases in physical activity and
insomnia are known to be more pronounced in midlife
and older adulthood,13,14 which would negatively affect
biology (biological/genetics pathway level) and perhaps
increase the use of health care (institutions level).
Zonderman et al.24 caution that factors during midlife
may vary across race/ethnicity and SES, and Muirhead25
suggests that it also might present unique challenges to
adults with serious mental illness.
Transdisciplinary Research in Cancer
Prevention During Midlife
Considering all of the risk factors for cancer increases the
complexity of resultant investigations, and embedding themncer disparities across thein a racial and socioeconomic
context increases it still further.
Extending this complexity
across the developmental con-
tinuum represents an even
greater challenge. Widening
our lens to increase the range
of factors that inﬂuence cancer
risk challenges long-held
modes of collaboration
among scientists in which
investigators operate largely
within their own disciplines,
and are rewarded for doing
so. In the traditional multi-
disciplinary mode of colla-
boration, although investi-
gators might come together
to solve a research problem,
each discipline historicallywww.ajpmonline.org
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for example, gather at the beginning of a research project
with separate but related research questions, collect and
analyze data independently, form independent conclu-
sions based on their separate research questions, and
then come together at the end of the project to try to
make sense of it all. These investigators leave the
collaboration with neither discernible change in their
approach nor a record of bold new insights and
discoveries. Likewise, they rarely bring new investigators
into the team as new research questions emerge from
their joint investigations. This mode of collaboration has
failed to provide a comprehensive picture of risk factors
and exposures for cancer during older adulthood that
takes into account race/ethnicity and SES across the
developmental continuum.
As has been argued previously by this and other authors,
the growing awareness that cancer risks and exposures at
multiple levels of inﬂuence interact in complex ways has
made clear the need for new modes of collaboration that
optimize the input of scholars from diverse back-
grounds.17,26 The most promising of these is transdisci-
plinary research, in which biological, behavioral, social, and
clinical investigators transcend and operate outside their
own boundaries and cultures to achieve synergy, inform
one another’s work, and create new intellectual spaces in
which no one discipline dominates and no way of knowing
is privileged over other ways.27 This allows the emergence
of new scientiﬁc ideas, questions, methods, and analyses
that would otherwise not have emerged had investigators
worked in more traditional and siloed ways. If transdisci-
plinarity were to be achieved, the outcome could be a
new multifaceted, broadly analytical understanding of
risk factors and exposures for cancer that occur dur-
ing midlife that could inform solutions and undergird
a well-integrated plan for their dissemination to
stakeholders.
Transdisciplinarity (which Rosenﬁeld28 deﬁnes as
“research in which exchanging information, altering
discipline-speciﬁc approaches, sharing resources, and
integrating disciplines achieves a common scientiﬁc
goal”) achieves the highest degree of collaboration of
any collaborative mode.29 It relies on early agreement on
research questions, methods, goals, and timelines, and it
may entail the development of multifaceted, broadly
analytical models for investigating problems. Hall
et al.30 identify four phases of transdisciplinary research,
namely development, conceptualization, integration, and
translation, each of which requires resources and support
from outside the team.
Rather than being intuitive, achieving and sustaining
transdisciplinarity requires learning and support. Yet
training in transdisciplinary collaboration has been slowMarch 2014to appear.31 For the most part, scholars continue to be
trained in the language and methods of their own
disciplines, and few existing training programs have been
systematically integrated into formal curricula at any
level of education. This hinders the transfer of knowledge
across disciplines and makes it difﬁcult to develop
broader analytical perspectives on inherently complex
human problems.
Increasing collaboration to the level of transdiscipli-
narity requires structural changes within institutions,
agencies, and universities. Needed are structures that
foster interactions and training across disciplines and
that prevent one discipline or group of disciplines
from being favored over others. Favoring one way of
knowing over others breeds the mistrust, conﬂict, mis-
understanding, and lack of appreciation for the expertise
of others that impede the free ﬂow of ideas between
disciplines. Mechanisms for avoiding these pitfalls
include creating shared instructional and work space
across disciplines, cross-training opportunities for pre-
and post-doctoral fellows, and setting up one central
administrator to oversee research awards so that the
work of one department, division, or school is not
privileged over others.29
In addition to providing training, institutions must
recognize and reward investigators who choose to work
transdisciplinarily. Teams of investigators working across
departments, divisions, and schools of universities
remain the exception rather than the rule, primarily
because of the nature of institutional incentives, and
universities continue to recognize and reward work by
individuals when it comes to tenure and promotion. At
the present time, tenure and promotion committees
largely pose an impediment to transdisciplinary research,
especially for junior faculty members. This is because
they fail to recognize the time required for establishing
teams and have traditionally favored single-authored
publications over multiauthored, collaboratively gener-
ated publications when evaluating faculty members for
advancement.
Translation
In order for knowledge generated by transdisciplinary
teams to result in decreased rates of cancer, its successful
translation into communities is required. This entails
making the boundaries of research teams sufﬁciently
permeable to allow knowledge sharing from basic science
to clinical science to program implementation and policy
change. In addition, new mechanisms are needed to
foster communication between these stakeholder groups
(e.g., university investigators and policymakers), because
they operate in a variety of settings and geographic areas,
Gehlert / Am J Prev Med 2014;46(3S1):S104–S109S108impeding opportunities for information-sharing and
collaboration.
Community stakeholder input is essential to successful
translation. For sustainable reductions in cancer inci-
dence rates to occur, research ﬁndings must be used in a
way that takes into account the context, value system,
and needs of each affected community, whether the
population is deﬁned by race or ethnicity, SES, phase of
development, or other factors (e.g., serious mental ill-
ness). Community-based participatory research involves
engaging community stakeholders at each stage of the
research process, thus enhancing the relevance and
effectiveness of interventions by producing research
ﬁndings that are meaningful to community members
and tailored to their needs.32 This engagement increases
the likelihood that interventions like primary cancer
prevention will be implemented and sustained. The
hypothesis testing suggested by the work of Keum and
colleagues16 and Amadou et al.33 on the 2012 CDC expert
panel would beneﬁt from input from community
stakeholders.
Effective translation also involves integrating primary
prevention messages across speciﬁc risk factors. Investi-
gators usually disseminate the knowledge that they
produce within their own disciplines and arenas (e.g.,
alcohol consumption, physical activity,34 workplace pol-
icy) rather than to researchers outside their disciplines
who could use their ﬁndings to create prevention
programs26 or to the public. The result is that research-
based recommendations are seldom coordinated and, in
fact, one set of recommendations may differ from an-
other even when both sets are based on similar evidence.
The consequence of this practice is a failure to adequately
inform healthcare providers, the public, and policy-
makers about our work in a way that can be understood
and used to reduce risk for cancer.Conclusion
The number of middle- and older-age people at risk for
developing some type of cancer during their lifetimes is
increasing as the Baby Boomer generation ages. Efforts
by the CDC to bring together investigators from a range
of disciplines involved in research on midlife exposure to
risk hold promise for turning knowledge about midlife
risk factors into interventions for preventing cancer
during older adulthood. Yet capturing intersections of
age, cancer risk, and cancer prevention, with considera-
tion for how they might vary by race/ethnicity, SES, and
other key factors, requires a new approach to collabora-
tion within the sciences. Successful translation of the
knowledge generated by these new collaborations
depends on communication along the continuum frombasic science to clinical science to program implementa-
tion and policy change. It also requires accounting for the
context, value system, and needs of affected commu-
nities, which can best be achieved through working in
partnership with community stakeholders.
A number of structural changes are needed to sufﬁ-
ciently capture the complexity of cancer risk during
midlife to allow for the development of interventions to
reduce rates of cancer during older adulthood. Univer-
sities and other research institutions need to develop and
implement curricula on transdisciplinary research as
early in the educational process as possible and to
institute mechanisms for rewarding transdisciplinary
collaboration. Only when investigators can integrate
their work, with input from stakeholders, can we begin
to create multifaceted solutions to reduce cancer
incidence rates during older adulthood. Likewise we
must disseminate the solutions in a consistent and
integrated way so that they are less confusing for
stakeholders and have a greater chance of improving
the nation’s health.Publication of this article was supported by grants NCI U54-
153460, NCI U54-155496, and UL1 TR000448.
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